John Buse

University of North Carolina School of Medicine, Chapel Hill, NC, United States of America

John Buse is the Verne S. Caviness Distinguished Professor, Chief of the Division of Endocrinology, Director of the Diabetes Center, and Senior Associate Dean for Clinical Research at the University of North Carolina School of Medicine in Chapel Hill, North Carolina, USA. He also serves as Director of the NC Translational and Clinical Sciences Institute working through a US National Institutes of Health-based consortium to accelerate the conversion of ideas and discoveries to products and policies for the improvement of health and well-being.

Dr Buse’s efforts combine clinical care, research, administration and teaching. He works with teams of investigators in diabetes clinical trials, comparative effectiveness research and translation of basic science towards clinical application. He has received numerous awards and honours, as well as international recognition for innovative patient-centred care. In addition, he has authored more than 400 journal publications and is a former President for Medicine & Science of the American Diabetes Association.

Juan Pablo Frias

National Research Institute, Los Angeles, CA, United States of America

Dr Frias is a Medical Director and Principal Investigator of the National Research Institute in Los Angeles, CA. He obtained his medical degree from Vanderbilt University School of Medicine and completed his Fellowship in Endocrinology, Diabetes and Metabolism at the University of California, San Diego. 

Dr Frias has held academic positions at the University of Colorado Health Sciences Center, Barbara Davis Center for Diabetes, and the University of California San Diego School of Medicine. He has been involved in diabetes and metabolism-related research for over 25 years and has authored numerous publications in this field.

Vanita Aroda

Brigham and Women's Hospital, Boston, MA, United States of America

Dr Aroda is the Director of Diabetes Clinical Research at the Brigham and Women's Hospital in Boston, MA, and is a member of the Faculty of Harvard Medical School. She completed her training in Internal Medicine and in Endocrinology, Diabetes and Metabolism at the University of California San Diego, CA, USA. 

Dr Aroda has an interest and published record in diabetes prevention and novel therapeutics in diabetes and weight management. She also has a strong interest in understanding therapeutic interventions in large multicenter clinical trials and their applicability and integration into care. Dr Aroda has years of experience in clinical trial conduct and leadership, has served as an investigator on the National Institutes of Health-funded GRADE, D2d, and DPPOS studies, and as the national or international signatory Principal Investigator for multiple therapeutic clinical trials. 

Dr Aroda currently serves on the Professional Practice Committee of the American Diabetes Association.

Nikolaus Marx

University Hospital Aachen, Aachen, Germany

Professor Marx is a Professor of Medicine and Cardiology and Head of the Department of Internal Medicine I, University Hospital Aachen, Germany. He received his medical training at the Universities of Mainz, Genf (Switzerland) and Düsseldorf, before obtaining his MD in 1994.

After a successful post-doctoral fellowship at Brigham and Women's Hospital, Harvard Medical School, Professor Marx later became a board-certified internist, then cardiologist, before specialising in intensive care medicine in internal medicine at the University of Ulm, Baden-Württemberg, Germany.

Professor Marx is a member of several organisations within the field of cardiology and diabetes, including the European Society of Cardiology, American Heart Association (AHA), German Diabetes Association and the European Association for the Study of Diabetes. In addition to reviewing submitted manuscript to numerous journals, including Circulation, Diabetologia, Diabetes, Diabetes Care, the Journal of Immunology and The Lancet, he is currently the Associate Editor for Diabetes and Vascular Disease Research. Professor Marx has served as President of the German Atherosclerosis Society (DGAF) from 2012 to 2015. He has also been a board member of the German Society of Cardiology (DGK) from 2017 to 2019.

Andreas Liebl

Center for Diabetes and Metabolism at the Fachklinik, Bad Heilbrunn, Germany

Center for Diabetes and Metabolism at the Fachklinik, Bad Heilbrunn, Germany

Dr Liebl is the Medical Director of the Center for Diabetes and Metabolism at the Fachklinik in Bad Heilbrunn, Germany. His research interests include insulin therapy, pharmacoeconomics, insulin pump therapy, intraperitoneal insulin therapy, continuous glucose monitoring and other diabetes technology. He is an advisor for the German Health Authorities and Payers Organisations.

Dr. Liebl has been a board member of ‘Diabetes Technology – Insulin Pumps and Glucose Sensors’ AGDT, which is a working group of the German Diabetes Association (DDG). He is also Past-Chairman and current board member of the Diabetes Expert Commission FKDB within the DDG, and an advisor for the German Health Authorities and Payers Organisations.

Dr. Liebl has authored or co-authored more than 100 national and international publications and has delivered numerous presentations at scientific meetings all over the world.

Melanie Davies

University of Leicester, Leicester, United Kingdom

Professor Davies is a Professor of Diabetes Medicine at the University of Leicester and an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust, Leicester, UK. She is based in the Diabetes Research Centre of the University of Leicester and is also the Co-Director of the Leicester Diabetes Centre, which has over 160 research staff, at the University Hospitals of Leicester NHS Trust.

Professor Davies’ research interests include the causes, screening, prevention, self-management and treatment of type 2 diabetes mellitus (T2DM). She is a National Institute for Health Research Senior Investigator Emeritus and a Director of the NIHR Leicester Biomedical Research Centre. Professor Davies is the Principal Investigator on a number of large global studies in the field of diabetes, obesity, physical activity, sedentary behaviour and cardiovascular disease, and has served as an expert for the National Institute for Health and Care Excellence (NICE) on a number of guideline groups. Professor Davies was co-chair of EASD/ADA’s Consensus Report on T2DM Management.

Professor Davies has published over 600 original articles in national and international peer-reviewed journals, such as the Lancet, NEJM and the BMJ and has over £60M of peer review grant funding. She was awarded the CBE (Commander of the Most Excellent Order of the British Empire) in the 2016 New Year’s Honour’s List for services to diabetes research and awarded Fellowship of the Academy of Medical Sciences in 2018.

Lena Landstedt-Hallin

Danderyd University Hospital, Stockholm, Sweden

Dr Landstedt-Hallin has been working as a clinician with a focus on diabetology for the majority of her professional career. She studied medicine at the Karolinska Institute (KI), Stockholm and received her MD in 1984. While studying for a PhD at KI, she also completed residencies in both Endocrinology/Diabetology and Internal Medicine.

She worked at the Danderyd University Hospital for over thirty years, where she was an investigator in local and multicentre studies, tutored PhD students, and also held administrative positions. Her latest published research was focused on real-world data regarding insulin degludec.

In 2013 Dr Landstedt-Hallin received the award of “Clinical diabetologist of the year” from her peers in the Swedish Association for Diabetologists (SFD). She is now semi-retired but continues to work clinically 1-2 days per week at a small hospital in Norrtälje, north of Stockholm, coaching people with type 1 diabetes.

John Wilding

University of Liverpool, Liverpool, United Kingdom

Professor John Wilding leads clinical research into Obesity, Diabetes and Endocrinology at the University of Liverpool, where he has worked since 1996, after training in Southampton and London. His clinical interests focus on caring for people with diabetes and obesity and he leads specialist services for obesity at Aintree University Hospital, which has been designated a Centre for Obesity Management by the European Association for the Study of Obesity.

Professor Wilding’s research team focusses on developing and evaluating treatments for obesity and diabetes. He has published over 350 papers and chapters and review articles, including clinical trials in diabetes and obesity and studies of adipocyte biology and metabolism.

Professor Wilding chairs the National Clinical Research Network Metabolic and Endocrine Speciality Group. He is Past-Chair of the UK Association for the Study of Obesity, a member of the Royal College of Physicians Advisory Group on Nutrition, Weight and Health, and President of the World Obesity Federation.

Ronald Goldenberg

LMC Diabetes & Endocrinology, Vaughan, Ontario, Canada

Dr Goldenberg is a consultant endocrinologist affiliated with LMC Diabetes & Endocrinology in Vaughan, Ontario. He completed his residency in Internal Medicine in 1987 and his fellowship in Endocrinology & Metabolism in 1989, both at the University of Toronto. His major areas of interest include clinical care of diabetes, obesity, dyslipidaemia and thyroid disorders.

Dr Goldenberg has been an investigator in a wide array of clinical trials in the areas of diabetes, hypertension, obesity and dyslipidaemia. He has been actively involved in Continuing Medical Education for the last 3 decades, with a strong focus on translating evidence-based medicine into practical patient care.

Dr Goldenberg was a councilor on the Diabetes Canada Clinical & Scientific Section Executive Committee from 2010 to 2016. He was also a member of the Steering Committee and an author for the 2013 CDA Clinical Practice Guidelines, lead author of the CDA March 2016 Interim Update and co-author of the November 2016 Interim Update on the Pharmacologic Management of Type 2 Diabetes. He has served on the Executive Committee and was an author for the 2018 Diabetes Canada Clinical Practice Guidelines.

Dr Goldenberg was affiliated with North York Branson/North York General Hospital from 1989 to 2020, where he served as Medical Director of the Diabetes Education Centre. He is Past-Chair of the Ontario Medical Association Section on Endocrinology & Metabolism and a previous President of the Toronto Diabetes Association.

Rachel Batterham

University College London (UCL), London, United Kingdom

Professor Batterham is a Professor of Obesity, Diabetes and Endocrinology at UCL, London, UK. She leads the University College London Hospital (UCLH) Bariatric Centre for Weight Management & Metabolic Surgery and the UCL Centre for Obesity Research, within the Department of Medicine. Professor Batterham is also the Director for the UCLH/UCL NIHR Biomedical Research Centre Obesity Research Theme, and the Royal College of Physicians’ Special Advisor on Obesity.

Professor Batterham has received several national and international awards for her work in obesity, including the Royal Society of Medicine’s Steven’s Lecture (2018), the Andre Mayer award from the World Obesity Federation (2016), and the Diabetes UK Rank Fund Nutrition Prize (2015). She has made significant clinical contributions to defining the management of people with obesity through her membership of the National Institute for Health and Care Excellence (NICE) Obesity Guideline Development Group.

Professor Batterham is Scientific Chair for the International Federation for Surgery for Obesity and Metabolic Diseases (IFSO) European Chapter, a Trustee for the Association for the Study of Obesity, and Council Member for British Obesity and Metabolic Surgery Society. She is passionate about reducing the stigma that people with obesity experience and ensuring that the patient voice is heard. Because of this, she has established a charity for people affected by obesity – the Obesity Empowerment Network UK.